These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9804917)
1. The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation. Brunson KL; Schultz L; Baram TZ Brain Res Dev Brain Res; 1998 Nov; 111(1):119-28. PubMed ID: 9804917 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Löscher W Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847 [TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone heterogeneous nuclear RNA (hnRNA) and immunoreactivity are induced in extrahypothalamic brain sites by kainic-acid-induced seizures and are modulated by estrogen. Foradori CD; Lund TD; Nagahara AH; Koenig JI; Handa RJ Brain Res; 2007 Aug; 1164():44-54. PubMed ID: 17631870 [TBL] [Abstract][Full Text] [Related]
4. Motor stimulation following bilateral injection of the group-I metabotropic glutamate receptor agonist into the dorsal striatum of rats: evidence against dependence on ionotropic glutamate receptors. Mao L; Wang JQ Psychopharmacology (Berl); 2000 Mar; 148(4):367-73. PubMed ID: 10928309 [TBL] [Abstract][Full Text] [Related]
5. The effect of 'Astressin', a novel antagonist of corticotropin releasing hormone (CRH), on CRH-induced seizures in the infant rat: comparison with two other antagonists. Baram TZ; Koutsoukos Y; Schultz L; Rivier J Mol Psychiatry; 1996 Jul; 1(3):223-6. PubMed ID: 9118346 [TBL] [Abstract][Full Text] [Related]
6. Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling. Haas KZ; Sperber EF; Opanashuk LA; Stanton PK; Moshé SL Hippocampus; 2001; 11(6):615-25. PubMed ID: 11811655 [TBL] [Abstract][Full Text] [Related]
7. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207 [TBL] [Abstract][Full Text] [Related]
8. L-glutamate-induced changes in intracellular calcium oscillation frequency through non-classical glutamate receptor binding in cultured rat myocardial cells. Winter CR; Baker RC Life Sci; 1995; 57(21):1925-34. PubMed ID: 7475942 [TBL] [Abstract][Full Text] [Related]
9. Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists. Baram TZ; Mitchell WG; Brunson K; Haden E Dev Neurosci; 1999 Nov; 21(3-5):281-9. PubMed ID: 10575251 [TBL] [Abstract][Full Text] [Related]
10. Ionotropic glutamate receptor antagonists inhibit the proliferation of granule cell precursors in the adult brain after seizures induced by pentylenetrazol. Jiang W; Wolfe K; Xiao L; Zhang ZJ; Huang YG; Zhang X Brain Res; 2004 Sep; 1020(1-2):154-60. PubMed ID: 15312797 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and morphological analysis of non-NMDA receptor mediated excitotoxicity in chick embryo retina. Chen Q; Olney JW; Price MT; Romano C Vis Neurosci; 1999; 16(1):131-9. PubMed ID: 10022484 [TBL] [Abstract][Full Text] [Related]
12. Calcium influx via ionotropic glutamate receptors causes long lasting inhibition of metabotropic glutamate receptor-coupled phosphoinositide hydrolysis. Facchinetti F; Hack NJ; Balázs R Neurochem Int; 1998 Sep; 33(3):263-70. PubMed ID: 9759922 [TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone: potentiation of cocaine-kindled seizures and lethality. Weiss SR; Nierenberg J; Lewis R; Post RM Epilepsia; 1992; 33(2):248-54. PubMed ID: 1547754 [TBL] [Abstract][Full Text] [Related]
14. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones. D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090 [TBL] [Abstract][Full Text] [Related]
15. Regulation of substantia nigra pars reticulata neuronal activity by excitatory amino acids. Schmitt P; Souliere F; Dugast C; Chouvet G Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):402-12. PubMed ID: 10551277 [TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Baram TZ; Schultz L Brain Res Dev Brain Res; 1991 Jul; 61(1):97-101. PubMed ID: 1914160 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological and pharmacological characteristics of ionotropic glutamate receptors in medial vestibular nucleus neurons: a whole cell patch clamp study in acutely dissociated neurons. Sakai N; Ujihara H; Ishihara K; Sasa M; Tanaka C Jpn J Pharmacol; 1996 Dec; 72(4):335-46. PubMed ID: 9015742 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons. Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949 [TBL] [Abstract][Full Text] [Related]
19. Regulation of cerebral microvessels by glutamatergic mechanisms. Fergus A; Lee KS Brain Res; 1997 Apr; 754(1-2):35-45. PubMed ID: 9134957 [TBL] [Abstract][Full Text] [Related]